The respiratory monitoring devices market size has grown strongly in recent years. It will grow from $1.81 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to increasing diagnosis of chronic respiratory conditions, expansion of sleep disorder testing, rising hospital monitoring requirements, availability of compact monitoring devices, growth in preventive healthcare practices.
The respiratory monitoring devices market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising adoption of connected health platforms, expansion of home diagnostic solutions, growing use of ai-driven clinical decision support, increasing focus on personalized respiratory care. Major trends in the forecast period include increasing adoption of wearable respiratory monitoring devices, rising use of continuous remote monitoring systems, growing integration of ai-based data analytics, expansion of home-based respiratory monitoring, enhanced focus on early detection technologies.
The increasing prevalence of pneumonia is expected to drive the growth of the respiratory monitoring devices market. Pneumonia is an infection that impacts one or both lungs, causing the alveoli (air sacs in the lungs) to fill with fluid or pus. This infection triggers inflammation in the lungs, which increases blood vessel permeability and leads to fluid leakage into the alveoli. Respiratory monitoring devices can assist in the early detection and management of pneumonia by offering real-time, continuous monitoring of respiratory rate and other vital signs. For example, in January 2023, the National Center for Biotechnology Information, a US-based government agency, reported that pneumonia affects around 120 million people globally each year, resulting in approximately 1.3 million deaths. Nearly 80% of pneumonia-related deaths in children occur in those under 2 years old in developing countries. As such, the rising prevalence of pneumonia is driving the demand for respiratory monitoring devices.
Major companies operating in the respiratory monitoring devices market are concentrating on product innovation, including smart inhalers equipped with embedded sensors that track usage patterns and inhalation quality. Smart inhalers are digitally enabled inhalation devices designed to monitor medication use, assess inhalation technique, and deliver real-time reminders or feedback to support improved management of respiratory diseases. For example, in December 2023, Adherium Ltd., a global digital health company, began production and launched its next-generation Hailie Smartinhaler in the U.S. market. The device captures physiological data such as inhalation flow rate in real time and converts a standard pressurized metered-dose inhaler (pMDI) into a connected smart inhaler to support asthma and COPD patients and enable enhanced remote monitoring. This innovation promotes medication adherence and delivers actionable insights to healthcare providers.
In March 2023, VitalConnect, a US-based provider of wearable and remote patient monitoring technologies, acquired Entelechon for $100 million. Through this acquisition, VitalConnect sought to strengthen its position in the digital health and monitoring devices market by expanding its portfolio to include advanced ingestible sensor technologies. Entelechon is a Germany-based company that provides respiratory monitoring devices.
Major companies operating in the respiratory monitoring devices market are Covidien LLC, GE Healthcare Inc., Philips Healthcare, ResMed Corp., Siemens Healthcare GmbH, CareFusion Corporation, Smiths Medical ASD Inc., Masimo Corporation, COSMED S.r.l., IITC Life Science Inc., Micro Idea Instruments Co. Ltd., OES Medical Ltd., Pulmonx Corporation, RWD Life Science Co. Ltd., Scientific Respiratory Equipment Inc., AirSep Corporation, Medtronic plc, Drägerwerk AG & Co. KGaA, Hamilton Medical India Pvt. Ltd., Getinge AB, Respiratory Motion Inc., Genstar Technologies Co. Inc., Avery Biomedical Devices Inc., Dynarex Corporation, Quality Medical Group Ltd.
Asia-Pacific was the largest region in the respiratory monitoring devices market in 2025. North America was the second-largest region in the respiratory monitoring devices market. The regions covered in the respiratory monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the respiratory monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the respiratory monitoring devices market by increasing costs of imported sensors, semiconductors, wireless modules, and display components used in capnographs, pulse oximeters, and spirometers. Healthcare facilities in North America and Europe are most affected due to reliance on imported electronics, while Asia-Pacific faces cost pressure on device exports. These tariffs are increasing device pricing and delaying technology upgrades. However, they are also encouraging domestic electronics manufacturing, regional assembly of monitoring devices, and innovation in cost-optimized respiratory diagnostics.
The respiratory monitoring devices market research report is one of a series of new reports that provides respiratory monitoring devices market statistics, including respiratory monitoring devices industry global market size, regional shares, competitors with a respiratory monitoring devices market share, detailed respiratory monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory monitoring devices industry. This respiratory monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Respiratory monitoring devices are used to evaluate the patient's respiratory organs and include patches applied to the body to measure respiration and heart rates. These devices help assess respiratory health, identify abnormalities, and guide treatment in clinical environments.
The primary categories of respiratory monitoring devices include capnographs, gas analyzers, pulse oximeters, peak flow meters, spirometers, polysomnography, and other related equipment. Capnographs, for example, are devices used to monitor the concentration of carbon dioxide in exhaled air, providing both a numerical readout and a graphical waveform tracing. These devices find applications in various medical contexts, including chronic obstructive pulmonary disease (COPD) management, the diagnosis and monitoring of infectious diseases, asthma treatment, and other respiratory health assessments. These devices are used by a range of end-users, including laboratories, hospitals, and individuals for home use.
The respiratory monitoring devices market consists of sales of pulse oximeters, capnography, spirometers, polysomnography (PSG), peak flow meters, gas analyzers, and others that are used to monitor respiration and heart rate. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The respiratory monitoring devices market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising adoption of connected health platforms, expansion of home diagnostic solutions, growing use of ai-driven clinical decision support, increasing focus on personalized respiratory care. Major trends in the forecast period include increasing adoption of wearable respiratory monitoring devices, rising use of continuous remote monitoring systems, growing integration of ai-based data analytics, expansion of home-based respiratory monitoring, enhanced focus on early detection technologies.
The increasing prevalence of pneumonia is expected to drive the growth of the respiratory monitoring devices market. Pneumonia is an infection that impacts one or both lungs, causing the alveoli (air sacs in the lungs) to fill with fluid or pus. This infection triggers inflammation in the lungs, which increases blood vessel permeability and leads to fluid leakage into the alveoli. Respiratory monitoring devices can assist in the early detection and management of pneumonia by offering real-time, continuous monitoring of respiratory rate and other vital signs. For example, in January 2023, the National Center for Biotechnology Information, a US-based government agency, reported that pneumonia affects around 120 million people globally each year, resulting in approximately 1.3 million deaths. Nearly 80% of pneumonia-related deaths in children occur in those under 2 years old in developing countries. As such, the rising prevalence of pneumonia is driving the demand for respiratory monitoring devices.
Major companies operating in the respiratory monitoring devices market are concentrating on product innovation, including smart inhalers equipped with embedded sensors that track usage patterns and inhalation quality. Smart inhalers are digitally enabled inhalation devices designed to monitor medication use, assess inhalation technique, and deliver real-time reminders or feedback to support improved management of respiratory diseases. For example, in December 2023, Adherium Ltd., a global digital health company, began production and launched its next-generation Hailie Smartinhaler in the U.S. market. The device captures physiological data such as inhalation flow rate in real time and converts a standard pressurized metered-dose inhaler (pMDI) into a connected smart inhaler to support asthma and COPD patients and enable enhanced remote monitoring. This innovation promotes medication adherence and delivers actionable insights to healthcare providers.
In March 2023, VitalConnect, a US-based provider of wearable and remote patient monitoring technologies, acquired Entelechon for $100 million. Through this acquisition, VitalConnect sought to strengthen its position in the digital health and monitoring devices market by expanding its portfolio to include advanced ingestible sensor technologies. Entelechon is a Germany-based company that provides respiratory monitoring devices.
Major companies operating in the respiratory monitoring devices market are Covidien LLC, GE Healthcare Inc., Philips Healthcare, ResMed Corp., Siemens Healthcare GmbH, CareFusion Corporation, Smiths Medical ASD Inc., Masimo Corporation, COSMED S.r.l., IITC Life Science Inc., Micro Idea Instruments Co. Ltd., OES Medical Ltd., Pulmonx Corporation, RWD Life Science Co. Ltd., Scientific Respiratory Equipment Inc., AirSep Corporation, Medtronic plc, Drägerwerk AG & Co. KGaA, Hamilton Medical India Pvt. Ltd., Getinge AB, Respiratory Motion Inc., Genstar Technologies Co. Inc., Avery Biomedical Devices Inc., Dynarex Corporation, Quality Medical Group Ltd.
Asia-Pacific was the largest region in the respiratory monitoring devices market in 2025. North America was the second-largest region in the respiratory monitoring devices market. The regions covered in the respiratory monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the respiratory monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the respiratory monitoring devices market by increasing costs of imported sensors, semiconductors, wireless modules, and display components used in capnographs, pulse oximeters, and spirometers. Healthcare facilities in North America and Europe are most affected due to reliance on imported electronics, while Asia-Pacific faces cost pressure on device exports. These tariffs are increasing device pricing and delaying technology upgrades. However, they are also encouraging domestic electronics manufacturing, regional assembly of monitoring devices, and innovation in cost-optimized respiratory diagnostics.
The respiratory monitoring devices market research report is one of a series of new reports that provides respiratory monitoring devices market statistics, including respiratory monitoring devices industry global market size, regional shares, competitors with a respiratory monitoring devices market share, detailed respiratory monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory monitoring devices industry. This respiratory monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Respiratory monitoring devices are used to evaluate the patient's respiratory organs and include patches applied to the body to measure respiration and heart rates. These devices help assess respiratory health, identify abnormalities, and guide treatment in clinical environments.
The primary categories of respiratory monitoring devices include capnographs, gas analyzers, pulse oximeters, peak flow meters, spirometers, polysomnography, and other related equipment. Capnographs, for example, are devices used to monitor the concentration of carbon dioxide in exhaled air, providing both a numerical readout and a graphical waveform tracing. These devices find applications in various medical contexts, including chronic obstructive pulmonary disease (COPD) management, the diagnosis and monitoring of infectious diseases, asthma treatment, and other respiratory health assessments. These devices are used by a range of end-users, including laboratories, hospitals, and individuals for home use.
The respiratory monitoring devices market consists of sales of pulse oximeters, capnography, spirometers, polysomnography (PSG), peak flow meters, gas analyzers, and others that are used to monitor respiration and heart rate. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Respiratory Monitoring Devices Market Characteristics
3. Respiratory Monitoring Devices Market Supply Chain Analysis
4. Global Respiratory Monitoring Devices Market Trends and Strategies
5. Respiratory Monitoring Devices Market Analysis of End Use Industries
7. Global Respiratory Monitoring Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Respiratory Monitoring Devices Total Addressable Market (TAM) Analysis for the Market
9. Respiratory Monitoring Devices Market Segmentation
10. Respiratory Monitoring Devices Market Regional and Country Analysis
11. Asia-Pacific Respiratory Monitoring Devices Market
12. China Respiratory Monitoring Devices Market
13. India Respiratory Monitoring Devices Market
14. Japan Respiratory Monitoring Devices Market
15. Australia Respiratory Monitoring Devices Market
16. Indonesia Respiratory Monitoring Devices Market
17. South Korea Respiratory Monitoring Devices Market
18. Taiwan Respiratory Monitoring Devices Market
19. South East Asia Respiratory Monitoring Devices Market
20. Western Europe Respiratory Monitoring Devices Market
21. UK Respiratory Monitoring Devices Market
22. Germany Respiratory Monitoring Devices Market
23. France Respiratory Monitoring Devices Market
24. Italy Respiratory Monitoring Devices Market
25. Spain Respiratory Monitoring Devices Market
26. Eastern Europe Respiratory Monitoring Devices Market
27. Russia Respiratory Monitoring Devices Market
28. North America Respiratory Monitoring Devices Market
29. USA Respiratory Monitoring Devices Market
30. Canada Respiratory Monitoring Devices Market
31. South America Respiratory Monitoring Devices Market
32. Brazil Respiratory Monitoring Devices Market
33. Middle East Respiratory Monitoring Devices Market
34. Africa Respiratory Monitoring Devices Market
36. Respiratory Monitoring Devices Market Competitive Landscape and Company Profiles
37. Respiratory Monitoring Devices Market Other Major and Innovative Companies
40. Respiratory Monitoring Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Respiratory Monitoring Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses respiratory monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for respiratory monitoring devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory monitoring devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Capnographs; Gas Analyzers; Pulse Oximeters; Peak Flow Meters; Spirometers; Polysomnographs; Others Types2) By Application: Chronic Obstructive Pulmonary Disease (COPD), Infectious Diseases; Asthma, Other Applications
3) By End-User: Laboratories; Hospitals; Home Use
Subsegments:
1) By Capnographs: Mainstream Capnographs; Sidestream Capnographs2) By Gas Analyzers: Single Gas Analyzers; Multi-Gas Analyzers
3) By Pulse Oximeters: Fingertip Pulse Oximeters; Handheld Pulse Oximeters; Wrist-Worn Pulse Oximeters; Tabletop Pulse Oximeters
4) By Peak Flow Meters: Disposable Peak Flow Meters; Digital Peak Flow Meters
5) By Spirometers: Desktop Spirometers; Handheld Spirometers; Tabletop Spirometers
6) By Polysomnographs: Portable Polysomnographs; Stationary Polysomnographs
7) By Other Types: Apnea Monitors; Home Sleep Testing Devices; Respiratory Gas Monitors
Companies Mentioned: Covidien LLC; GE Healthcare Inc.; Philips Healthcare; ResMed Corp.; Siemens Healthcare GmbH; CareFusion Corporation; Smiths Medical ASD Inc.; Masimo Corporation; COSMED S.r.l.; IITC Life Science Inc.; Micro Idea Instruments Co. Ltd.; OES Medical Ltd.; Pulmonx Corporation; RWD Life Science Co. Ltd.; Scientific Respiratory Equipment Inc.; AirSep Corporation; Medtronic plc; Drägerwerk AG & Co. KGaA; Hamilton Medical India Pvt. Ltd.; Getinge AB; Respiratory Motion Inc.; Genstar Technologies Co. Inc.; Avery Biomedical Devices Inc.; Dynarex Corporation; Quality Medical Group Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Respiratory Monitoring Devices market report include:- Covidien LLC
- GE Healthcare Inc.
- Philips Healthcare
- ResMed Corp.
- Siemens Healthcare GmbH
- CareFusion Corporation
- Smiths Medical ASD Inc.
- Masimo Corporation
- COSMED S.r.l.
- IITC Life Science Inc.
- Micro Idea Instruments Co. Ltd.
- OES Medical Ltd.
- Pulmonx Corporation
- RWD Life Science Co. Ltd.
- Scientific Respiratory Equipment Inc.
- AirSep Corporation
- Medtronic plc
- Drägerwerk AG & Co. KGaA
- Hamilton Medical India Pvt. Ltd.
- Getinge AB
- Respiratory Motion Inc.
- Genstar Technologies Co. Inc.
- Avery Biomedical Devices Inc.
- Dynarex Corporation
- Quality Medical Group Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.99 Billion |
| Forecasted Market Value ( USD | $ 2.89 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
